Liver Transplant Recipients Older Than 60 Years Show Executive and Memory Function Improvement Comparable to Younger Recipients.


Journal

Psychosomatics
ISSN: 1545-7206
Titre abrégé: Psychosomatics
Pays: England
ID NLM: 0376506

Informations de publication

Date de publication:
Historique:
received: 26 12 2018
revised: 21 01 2019
accepted: 21 01 2019
pubmed: 18 2 2019
medline: 1 8 2020
entrez: 18 2 2019
Statut: ppublish

Résumé

Increasing numbers of patients over the age of 60 are undergoing liver transplantation. We sought to determine whether age or clinical morbidities were associated with pre- and post-transplant executive and memory performance using the Brief Test of Adult Cognition by Telephone (BTACT). Participants included 36 recipients with n = 20 in the older group (>60 y) and n = 16 in the younger group (≤60 years). The BTACT was administered an average of 3 months before transplant, and at follow-up post-transplant intervals of 3, 6, and 9 months. BTACT composite scores for memory and executive function with age and education norms were obtained. Older recipients were more likely to have hepatocellular carcinoma, a lower biological MELD score at transplant, less cellular rejection, and fewer post-operative hospital days. Older and younger recipients showed comparable pre-transplant executive and memory function and comparable post-transplant improvement. Both older and younger patients showed statistically significant improvement in executive function scores at 3 months post-transplant and maintained improvement at 6 and 9 months. Memory function improved significantly in older patients by 6 months post-transplant but did not improve significantly in the younger group. Older liver transplant recipients were more likely to have hepatocellular carcinoma and a lower biological MELD score than younger recipients, but both age groups showed comparable pre-transplant cognitive performance and post-transplant cognitive improvement. Additionally, a normed telephone test can be used to effectively screen and track executive and memory function post-transplant.

Sections du résumé

BACKGROUND
Increasing numbers of patients over the age of 60 are undergoing liver transplantation.
OBJECTIVE
We sought to determine whether age or clinical morbidities were associated with pre- and post-transplant executive and memory performance using the Brief Test of Adult Cognition by Telephone (BTACT).
METHODS
Participants included 36 recipients with n = 20 in the older group (>60 y) and n = 16 in the younger group (≤60 years). The BTACT was administered an average of 3 months before transplant, and at follow-up post-transplant intervals of 3, 6, and 9 months. BTACT composite scores for memory and executive function with age and education norms were obtained.
RESULTS
Older recipients were more likely to have hepatocellular carcinoma, a lower biological MELD score at transplant, less cellular rejection, and fewer post-operative hospital days. Older and younger recipients showed comparable pre-transplant executive and memory function and comparable post-transplant improvement. Both older and younger patients showed statistically significant improvement in executive function scores at 3 months post-transplant and maintained improvement at 6 and 9 months. Memory function improved significantly in older patients by 6 months post-transplant but did not improve significantly in the younger group.
CONCLUSION
Older liver transplant recipients were more likely to have hepatocellular carcinoma and a lower biological MELD score than younger recipients, but both age groups showed comparable pre-transplant cognitive performance and post-transplant cognitive improvement. Additionally, a normed telephone test can be used to effectively screen and track executive and memory function post-transplant.

Identifiants

pubmed: 30772017
pii: S0033-3182(19)30023-4
doi: 10.1016/j.psym.2019.01.008
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

488-498

Informations de copyright

Copyright © 2019 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.

Auteurs

Tanis J Ferman (TJ)

Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL.

Andrew P Keaveny (AP)

Department of Transplantation, Mayo Clinic, Jacksonville, FL.

Terry Schneekloth (T)

Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN.

Michael G Heckman (MG)

Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL.

Emily Vargas (E)

Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, FL.

Adriana Vasquez (A)

Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL.

Teresa Rummans (T)

Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL; Department of Psychiatry & Psychology, Mayo Clinic, Rochester, MN.

C Burcin Taner (CB)

Department of Transplantation, Mayo Clinic, Jacksonville, FL.

Shehzad K Niazi (SK)

Department of Psychiatry & Psychology, Mayo Clinic, Jacksonville, FL; Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, FL. Electronic address: niazi.shehzad@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH